GLP-1 medications are metabolized through proteolytic degradation, not through the liver's cytochrome P450 enzyme system
[DOI] [PubMed] [Google Scholar] 5.9 Meters Biopharma, Inc
Dysbiosis, through the lack of appropriate immunoregulatory and barrier factors, such as, e.g., short-chain fatty acids, causes inappropriate activation of the immune system, resulting in epithelial inflammation, epithelial barrier damage and disease development [55, 57,58,59,60,61]
Treating vitamin B 12 deficiency Treatment for this condition involves replacing the missing vitamin B 12
Itsinvolved in the production of the myelin sheath around the nerves and the conduction of nerve impulses